Ultravist 300 mg (50 & 100 ml)

Ultravist® (iopromide) Injection is an iodinated contrast agent indicated for use in ;

1.Intra-arterial Procedures: 300 mg I/mL for cerebral arteriography and peripheral arteriography; 370 mg I/mL for coronary arteriography and left ventriculography, visceral angiography, and aortography.

2. Intravenous Procedures: 240 mg I/mL for peripheral venography; 300 mg I/mL for excretory urography; 300 mg I/mL and 370 mg I/mL for contrast Computed Tomography (CT) of the head and body (intrathoracic, intraabdominal and retroperitoneal regions) for the evaluation of neoplastic and non-neoplastic lesions. The usefulness of contrast enhancement for the investigation of the retrobulbar space and of low grade or infiltrative glioma has not been demonstrated. It is also available in 370 mg dosage 50 & 100 ml.

Note: Ultravist is a temperature sensitive drug & needs to be stored in 2-8 degree Celsius.

Manufacturer: Bayer (Sold by Zydus German Remedies in India)

The most important adverse drug reactions in patients receiving ULTRAVIST are anaphylactoid shock, contrast induced acute kidney injury, coma, cerebral infarction, stroke, brain edema, convulsion, arrhythmia, cardiac arrest, myocardial ischemia, myocardial infarction, cardiac failure, bradycardia, cyanosis, hypotension, shock, dyspnea, pulmonary edema, respiratory insufficiency and aspiration.